Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07865507

Divergent Long-Term Clinical Courses in Two Men With Breast Cancer

Sponsor: Azerbaijan Medical University

View on ClinicalTrials.gov

Summary

This observational study describes the long-term clinical courses of two men with hormone receptor-positive, HER2-negative invasive breast cancer. Although both tumors had similar receptor profiles, the patients experienced very different outcomes. One patient developed progressive locally advanced disease followed by metastases to the lungs, bones, liver, mediastinal lymph nodes, and bilateral axillary lymph nodes after multiple systemic treatments and without definitive breast surgery. The second patient underwent mastectomy and axillary surgery followed by adjuvant chemotherapy and had no documented locoregional recurrence approximately 9.6 years after surgery. The study compares clinical stage, lymph-node involvement, pathology, treatment exposure, imaging findings, and follow-up to illustrate that prognosis in male breast cancer cannot be determined from hormone receptor status or a single biomarker alone

Official title: Two Cases of Hormone Receptor-Positive, HER2-Negative Male Breast Cancer With Divergent Long-Term Clinical Courses

Key Details

Gender

MALE

Age Range

50 Years - 60 Years

Study Type

OBSERVATIONAL

Enrollment

2

Start Date

2016-11-16

Completion Date

2026-08-21

Last Updated

2026-10-08

Healthy Volunteers

No

Interventions

OTHER

Follow-up

Clinical treatments, diagnostic evaluations, imaging, pathology assessment, and follow-up were provided as part of routine clinical care and were not assigned by the observational study protocol. The study retrospectively reviewed these exposures and their associated longitudinal outcomes

Locations (1)

The National Oncology Center

Baku, Nasimi, Azerbaijan